Usually, NFKBIA functions as a tumour suppressor and has the potential to be introduced as a novel anti-tumour agent [27, 28], whether it can reverse pulmonary vascular remodeling in PAH is not yet clear. This evidence concerns the gene NFKBIA and neoplasm.